Key details of the duodenal-jejunal bypass in type 2 diabetes mellitus rats

被引:1
|
作者
Han, Li-Ou [1 ]
Zhou, Li-Hong [2 ]
Cheng, Su-Jun [2 ]
Song, Chun [1 ]
Song, Chun-Fang [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin 150001, Heilongjiang Pr, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Endocrinol, Harbin 150001, Heilongjiang Pr, Peoples R China
关键词
Duodenal-jejunal bypass; Type 2 diabetes mellitus; Minimally invasive surgery; Fast-track surgery; Damage control surgery; Permissive underfeeding; Goal-directed volume therapy; Y GASTRIC BYPASS; DAMAGE CONTROL; MODEL; COMPLICATIONS; MANAGEMENT; SURGERY; DISEASE; DIET;
D O I
10.3748/wjg.v17.i45.5021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate which surgical techniques and perioperative regimens yielded the best survival rates for diabetic rats undergoing gastric bypass. METHODS: We performed Roux-en-Y gastric bypass with reserved gastric volume, a procedure in which gastrointestinal continuity was reestablished while excluding the entire duodenum and proximal jejunal loop. We observed the procedural success rate, long-term survival, and histopathological sequelae associated with a number of technical modifications. These included: use of anatomical markers to precisely identify Treitz's ligament; careful dissection along surgical planes; careful attention to the choice of regional transection sites; reconstruction using full-thickness anastomoses; use of a minimally invasive procedure with prohemostatic pretreatment and hemorrhage control; prevention of hypo-thermic damage; reduction in the length of the procedure; and accelerated surgical recovery using fast-track surgical modalities such as perioperative permissive underfeeding and goal-directed volume therapy. RESULTS: The series of modifications we adopted reduced operation time from 110.02 +/- 12.34 min to 78.39 +/- 7.26 min ( P < 0.01), and the procedural success rate increased from 43.3% (13/30) to 90% (18/20) (P < 0.01), with a long-term survival of 83.3% (15/18) (P < 0.01). CONCLUSION: Using a number of fast-track and damage control surgical techniques, we have successfully established a stable model of gastric bypass in diabetic rats. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:5021 / 5027
页数:7
相关论文
共 50 条
  • [21] Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal-Jejunal Bypass Liner
    de Moura, Eduardo G. H.
    Martins, Bruno C.
    Lopes, Guilherme S.
    Orso, Ivan R.
    de Oliveira, Suzana L.
    Galvao Neto, Manoel P.
    Santo, Marco A.
    Sakai, Paulo
    Ramos, Almino C.
    Garrido Junior, Arthur B.
    Mancini, Marcio C.
    Halpern, Alfredo
    Cecconello, Ivan
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (02) : 183 - 189
  • [22] Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass
    Han, Haifeng
    Wang, Lei
    Du, Hao
    Jiang, Jianjun
    Hu, Chunxiao
    Zhang, Guangyong
    Liu, Shaozhuang
    Zhang, Xiang
    Liu, Teng
    Hu, Sanyuan
    OBESITY SURGERY, 2015, 25 (10) : 1802 - 1809
  • [23] Type 2 Diabetes Control in a Nonobese Rat Model Using Sleeve Gastrectomy with Duodenal-Jejunal Bypass (SGDJB)
    Sun, Dong
    Liu, Shaozhuang
    Zhang, Guangyong
    Chen, Weijie
    Yan, Zhibo
    Hu, Sanyuan
    OBESITY SURGERY, 2012, 22 (12) : 1865 - 1873
  • [24] Mechanism of Bile Acid Reabsorption in the Biliopancreatic Limb After Duodenal-Jejunal Bypass in Rats
    Ueno, Tomotaka
    Tanaka, Naoki
    Imoto, Hirofumi
    Maekawa, Masamitsu
    Kohyama, Atsushi
    Watanabe, Kazuhiro
    Motoi, Fuyuhiko
    Kamei, Takashi
    Unno, Michiaki
    Naitoh, Takeshi
    OBESITY SURGERY, 2020, 30 (07) : 2528 - 2537
  • [25] Comparison of Great Curvature Plication with Duodenal-Jejunal Bypass (GCP-DJB) and Sleeve Gastrectomy (SG) on Metabolic Indices and Gut Hormones in Type 2 Diabetes Mellitus Rats
    Qiu, Nian-Cun
    Li, Wei
    Liu, Miao-E
    Cen, Xiao-Xia
    Shan, Cheng-Xiang
    Zhang, Wei
    Liu, Qing
    Wang, Yang
    Zhu, Ya-Ting
    Qiu, Ming
    OBESITY SURGERY, 2018, 28 (12) : 4014 - 4021
  • [26] Duodenal-jejunal bypass for the treatment of type 2 diabetes in Chinese patients with an average body mass index &lt;24 kg/m2
    Jiang, Feizhao
    Zhu, Hengliang
    Zheng, Xiaofeng
    Tu, Jinfu
    Zhang, Weijian
    Xie, Xuemeng
    SURGERY FOR OBESITY AND RELATED DISEASES, 2014, 10 (04) : 641 - 646
  • [27] Duodenal-jejunal bypass ameliorates MASLD in rats by regulating gut microbiota and bile acid metabolism through FXR pathways
    Ren, Mengting
    Xia, Yi
    Pan, Hanghai
    Zhou, Xinxin
    Yu, Mosang
    Ji, Feng
    HEPATOLOGY COMMUNICATIONS, 2025, 9 (02)
  • [28] miR-320 mediates diabetes amelioration after duodenal-jejunal bypass via targeting adipoR1
    Guo Wei
    Shao Yi
    Dai Yong
    Liu Shaozhuang
    Zhang Guangyong
    Hu Sanyuan
    SURGERY FOR OBESITY AND RELATED DISEASES, 2018, 14 (07) : 960 - 971
  • [29] Duodenal-jejunal bypass changes the composition of the gut microbiota
    Hideya Kashihara
    Mitsuo Shimada
    Kozo Yoshikawa
    Jun Higashijima
    Toshihiro Nakao
    Masaaki Nishi
    Chie Takasu
    Surgery Today, 2017, 47 : 137 - 140
  • [30] Comparative Effects of Bile Diversion and Duodenal-Jejunal Bypass on Glucose and Lipid Metabolism in Male Diabetic Rats
    Zhang, Xiang
    Liu, Teng
    Wang, Yanmin
    Zhong, Mingwei
    Zhang, Guangyong
    Liu, Shaozhuang
    Wu, Tongzhi
    Rayner, Christopher K.
    Hu, Sanyuan
    OBESITY SURGERY, 2016, 26 (07) : 1565 - 1575